Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Adolescent survival rates for osteosarcoma have not improved for 20 years

01.03.2004


More research is urgently needed says cancer surgeon



New treatments and more research are urgently needed in order to increase the numbers of adolescents who survive bone cancer, according to a leading cancer surgeon.

Osteosarcoma is the third most common cancer in young people*, yet during the past 20 years little research has been carried out into developing improved therapies, and survival rates have remained unchanged with only 54 per cent of patients alive after five years, says Robert Grimer, a consultant orthopaedic oncologist at The Royal Orthopaedic Hospital NHS Trust in Birmingham.


He will tell the Teenage Cancer Trust’s Third International Conference on Cancer and the Adolescent today (Monday 1 March): "Osteosarcoma arises most often in teenagers, yet treatments have not improved during the past 20 years. Chemotherapy and removing part or all of the affected limb are still the standard therapies available. There is an urgent need for new treatments to be developed that are more effective, but kinder to the patients themselves.

"It is a sad fact that, while survival rates in many other cancers have been improving, they have remained static for so long for osteosarcoma."

Fifty per cent of osteosarcomas in adolescents and young adults occur in the bones around the knee, but they can occur in any bone. "The symptoms are very non-specific and delays in diagnosis are common," said Mr Grimer. "This is a problem because if the tumour has had time to spread to other parts of the body, it is very difficult to treat successfully. GPs need to be aware of this, and to refer patients immediately for further investigation if they have symptoms such as pain and swelling of a bone or in the area of a bone.

He said that more research needed to be done not only on improving and evaluating treatments, but also on the best ways to explain risks adequately to adolescents so that they could make properly informed decisions.

"In adolescents there are a number of dilemmas that need to be explored and which may affect decision-making for the individual. Firstly, can the tumour be safely resected (cut out) with a low risk of the cancer recurring? In many, this will be the case, but in some there will be a true dilemma between resection and limb salvage versus amputation. In this situation the risks and benefits need to be clarified.

"If there has been a poor response by the tumour to chemotherapy and it is not possible to leave a clear margin of unaffected bone around the diseased area, then the risk of local recurrence of the tumour may be as high as 30 per cent. Tumour recurrence is dangerous, with a high risk of amputation and also of metastatic disease developing. The alternative procedure is an amputation – something that is not attractive to the vast majority of patients. Thus there is a conflict between a ‘safe’ amputation and a ‘risky’ limb salvage operation. Adolescents take risks and many will accept this risk of local recurrence to keep their limb. Limb salvage surgery is not without problems, however, including poor function, infection, breakages and the almost certain need for further surgery in the future.

"Exploring how these risks and benefits can be conveyed to adolescents to help them make sensible choices is part of the art and challenge of dealing with adolescents."

Dr Jeremy Whelan, a consultant medical oncologist at The Meyerstein Institute of Oncology, Middlesex Hospital in London, will tell the conference that it is vital that osteosarcoma in adolescents should be treated by specialists who not only understand the disease but also their patients. He agreed with Mr Grimer that more research was urgently needed, especially as there was evidence from clinical trials to suggest that osteosarcoma was not treated so well in the UK as in other European countries and the USA. But he highlighted the problems that researchers encountered in setting up clinical trials.

"I am involved in setting up a new trial for osteosarcoma with groups in Europe and the US as we all recognise that we need better results from treatment and that solutions will come quicker by working together. However, such trials are very difficult to establish, fund and run, mostly because of the tightening of regulations; we have spent two and a half years so far trying to set up this trial, and it is still not opened," he said.


Notes
* New figures for the year 2000 show that between 1979 and 2000 in England there were 1,057 cases of osteosarcoma in young people between the ages of 13 and 24. This represents a rate of 0.59 cases per 100,000 of the population in this age group.

Margaret Willson | alfa

More articles from Health and Medicine:

nachricht 'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers
16.02.2018 | National University of Science and Technology MISIS

nachricht New process allows tailor-made malaria research
16.02.2018 | Eberhard Karls Universität Tübingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

Im Focus: Autonomous 3D scanner supports individual manufacturing processes

Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).

Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Fingerprints of quantum entanglement

16.02.2018 | Information Technology

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers

16.02.2018 | Health and Medicine

Hubble sees Neptune's mysterious shrinking storm

16.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>